Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Becky Kinkead

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Current Opinion in Pharmacology|January 12, 2002
Neurotensin: an endogenous antipsychotic?Becky Kinkead, Charles B Nemeroff
International Review of Neurobiology|March 10, 2004
Neurotensin, schizophrenia, and antipsychotic drug actionBecky Kinkead, Charles B Nemeroff
Biology of Reproduction|December 28, 2007
Gene-environment interactions, not neonatal growth hormone deficiency, time puberty in female rhesus monkeysMark E Wilson, Becky Kinkead
Seminars in Clinical Neuropsychiatry|May 3, 2003
Do neurotensin receptor agonists represent a novel class of antipsychotic drugs?Ricardo Cáceda, Becky Kinkead, Charles B Nemeroff
International Review of Neurobiology|March 14, 2007
Involvement of neuropeptide systems in schizophrenia: human studiesRicardo Cáceda, Becky Kinkead, Charles B Nemeroff
Peptides|August 8, 2006
Neurotensin: role in psychiatric and neurological diseasesRicardo Cáceda, Becky Kinkead, Charles B Nemeroff
The Journal of Clinical Psychiatry|February 4, 2003
Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosingCharles B Nemeroff, Becky Kinkead, Jeffrey Goldstein
Schizophrenia Research|November 23, 2011
The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotionRicardo Cáceda, Elisabeth B Binder, Becky Kinkead, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 2005
Genetic analysis of the hypothalamic neurotensin systemSteven J Garlow, Ericka Boone, Becky Kinkead, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 16, 2005
Virally mediated increased neurotensin 1 receptor in the nucleus accumbens decreases behavioral effects of mesolimbic system activationRicardo Cáceda, Becky Kinkead, Michael J Owens, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Current Opinion in Pharmacology|January 12, 2002
Neurotensin: an endogenous antipsychotic?Becky Kinkead, Charles B Nemeroff
International Review of Neurobiology|March 10, 2004
Neurotensin, schizophrenia, and antipsychotic drug actionBecky Kinkead, Charles B Nemeroff
Biology of Reproduction|December 28, 2007
Gene-environment interactions, not neonatal growth hormone deficiency, time puberty in female rhesus monkeysMark E Wilson, Becky Kinkead
Seminars in Clinical Neuropsychiatry|May 3, 2003
Do neurotensin receptor agonists represent a novel class of antipsychotic drugs?Ricardo Cáceda, Becky Kinkead, Charles B Nemeroff
International Review of Neurobiology|March 14, 2007
Involvement of neuropeptide systems in schizophrenia: human studiesRicardo Cáceda, Becky Kinkead, Charles B Nemeroff
Peptides|August 8, 2006
Neurotensin: role in psychiatric and neurological diseasesRicardo Cáceda, Becky Kinkead, Charles B Nemeroff
The Journal of Clinical Psychiatry|February 4, 2003
Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosingCharles B Nemeroff, Becky Kinkead, Jeffrey Goldstein
Schizophrenia Research|November 23, 2011
The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotionRicardo Cáceda, Elisabeth B Binder, Becky Kinkead, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 2005
Genetic analysis of the hypothalamic neurotensin systemSteven J Garlow, Ericka Boone, Becky Kinkead, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 16, 2005
Virally mediated increased neurotensin 1 receptor in the nucleus accumbens decreases behavioral effects of mesolimbic system activationRicardo Cáceda, Becky Kinkead, Michael J Owens, et al.
Pageof 5